Geneos Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-210	Closed	-$26.4K	–	2935
2025 Q2	$26.4K	Sell	210 -341	-62%	-$39.1K	﹤0.01%	1898
2025 Q1	$60.9K	Buy	551 +457	+486%	+$57.9K	﹤0.01%	1815
2024 Q4	$12.8K	Hold	94	–	–	﹤0.01%	1942
2024 Q3	$10.8K	Buy	+94	New	+$12.9K	﹤0.01%	1813
2024 Q2	–	Sell	-7	Closed	-$965	–	2143
2024 Q1	$965	Buy	+7	New	+$956	﹤0.01%	2027
2021 Q2	–	Sell	-11	Closed	-$1K	–	3022
2021 Q1	$1K	Buy	+11	New	+$1.15K	﹤0.01%	3041
2020 Q4	–	Sell	-50	Closed	-$4K	–	2962
2020 Q3	$4K	Sell	50 -250	-83%	-$28.9K	﹤0.01%	2266
2020 Q2	$39K	Sell	300 -190	-39%	-$21K	﹤0.01%	1327
2020 Q1	$43K	Hold	490	–	–	﹤0.01%	1185
2019 Q4	$53K	Buy	+490	New	+$51.3K	﹤0.01%	1220